Representative before the EPO

Employment test 201 - 500 employees
Company dna awapatent
operating since 1897
1295.56
AWA
Headquarter in Malmö and 16 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 13 EP applications Maria Elisabeth Stenbäck has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12807837

TREATMENT OF PROSTATE CANCER AND A METHOD FOR DETERMINING THE PROGNOSIS FOR PROSTATE CANCER PATIENTS

IPC classification:
A61K 38/17, G01N 33/574, A61P 35/00, A61P 13/08
Agent:
Multiple attorneys, AWA
Status:
EXAMINATION IN PROGRESS
EP11838925

COMBINATION THERAPY FOR PROSTATE CANCER USING BOTANICAL COMPOSITIONS AND BICALUTAMIDE

IPC classification:
A61K 31/165, A61K 36/539, A61K 36/537, A61K 36/074
Agent:
Maria Elisabeth Stenbäck, AWA
Status:
EXAMINATION IN PROGRESS
EP12815365

STABILIZER, BARRIER DISC AND WOUND DRESSING COMPRISING STABILIZER, METHOD FOR CONTROLLING THE POSITION OF A WOUND DRESSING OR BARRIER DISC, AND METHOD FOR FACILITATING DRAINAGE FROM A WOUND DRESSING OR BARRIER DISC IN NEGATIVE PRESSURE WOUND TREATMENT

IPC classification:
A61M 27/00, A61M 1/00, A61F 13/00, A61B 17/02
Agent:
Magnus Berglund, Ström & Gulliksson AB
Agent:
Multiple attorneys, AWA
Status:
EXAMINATION IN PROGRESS
EP12740999

DIPHENYL SUBSTITUTED CYCLOHEXANE DERIVATIVES, USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS BETA

IPC classification:
A61K 31/09, A61K 31/05, C07C 43/29, C07C 39/42, A61P 29/00, A61P 25/00
Applicant:
Acadia Pharmaceuticals Inc.
Agent:
Multiple attorneys, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12743185

TREATMENT OF NEURODEGENERATIVE DISEASES

IPC classification:
A61K 31/192, C07C 49/792, A61P 25/16
Applicant:
Acadia Pharmaceuticals Inc.
Agent:
Multiple attorneys, AWA
Status:
GRANT OF PATENT INTENDED
EP12824195

SKIN ADHESIVE AGENT FOR MAMMOGRAPHY PROCEDURES

IPC classification:
A61B 5/05
Agent:
Multiple attorneys, AWA
Status:
GRANT OF PATENT INTENDED
EP12759487

NOVEL MANGANESE COMPRISING NANOSTRUCTURES

IPC classification:
A61K 49/18, A61K 49/12, B82Y 15/00, B82Y 5/00
Agent:
Ström & Gulliksson AB
Agent:
Multiple attorneys, AWA
Status:
GRANT OF PATENT INTENDED
EP12152413

Novel galactoside inhibitors of galectins

IPC classification:
A61P 35/00, A61P 29/00, A61P 19/02, A61K 31/7028, C07H 15/18
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Agent:
Maria Elisabeth Stenbäck, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13163748

Substituted nucleoside and nucleotide analogs

IPC classification:
C07H 19/20, C07H 19/16, C07H 19/14, C07H 19/12, C07H 19/06, A61P 31/12, A61K 31/7042, A61K 31/7076, A61K 31/7068, A61K 31/7052, A61K 31/7064
Agent:
Maria Elisabeth Stenbäck, AWA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12790572

FORMULATION OF SOLID NANO-SIZED PARTICLES IN A GEL-FORMING SYSTEM

IPC classification:
A61K 49/04
Applicant:
Technical University of Denmark (Danmarks Tekniske Universitet (DTU))
Agent:
Multiple attorneys, AWA
Status:
GRANT OF PATENT INTENDED
EP13708242

SUBSTITUTED 4,5-DIHYDRO-2H-BENZO[E]INDAZOLE-9-CARBOXYLATES FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS

IPC classification:
A61K 31/416, C07D 409/04, C07D 231/54, A61P 3/10
Applicant:
Council of Scientific & Industrial Research
Agent:
Multiple attorneys, AWA
Status:
PATENT GRANTED
EP11827047

PHENYLPIPERIDINE COMPOUNDS FOR THE TREATMENT OF DEMENTIA

IPC classification:
A61P 25/28, A61K 31/445
Agent:
Maria Elisabeth Stenbäck, AWA
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11839542

MODULAR ANTI-REVERSIBLE POWER SPRING APPARATUS AND METHOD

IPC classification:
E06B 9/44, E06B 9/60
Agent:
EIP Europe LLP
Agent:
Multiple attorneys, AWA
Status:
PATENT GRANTED

Please Sign in to use this feature